Serena et al. reported that human primary mesoangioblasts restored dystrophin and distribution by cell-cell fusion via an in vitro model of human DMD skeletal muscle tissue-on-a-chip more efficiently than human myoblasts (Serena et al., 2016). The gene discussed is DMD; the disease is Duchenne muscular dystrophy.